nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—Pneumonia—Vincristine—sarcoma	0.00732	0.00732	CcSEcCtD
Roflumilast—Depression—Vincristine—sarcoma	0.00726	0.00726	CcSEcCtD
Roflumilast—Connective tissue disorder—Thiotepa—sarcoma	0.00724	0.00724	CcSEcCtD
Roflumilast—Weight decreased—Mitoxantrone—sarcoma	0.00719	0.00719	CcSEcCtD
Roflumilast—Pneumonia—Mitoxantrone—sarcoma	0.00713	0.00713	CcSEcCtD
Roflumilast—Urinary tract infection—Mitoxantrone—sarcoma	0.00689	0.00689	CcSEcCtD
Roflumilast—Cardiac disorder—Thiotepa—sarcoma	0.00684	0.00684	CcSEcCtD
Roflumilast—Immune system disorder—Thiotepa—sarcoma	0.00665	0.00665	CcSEcCtD
Roflumilast—Sinusitis—Mitoxantrone—sarcoma	0.00665	0.00665	CcSEcCtD
Roflumilast—Mediastinal disorder—Thiotepa—sarcoma	0.00664	0.00664	CcSEcCtD
Roflumilast—Mental disorder—Thiotepa—sarcoma	0.00645	0.00645	CcSEcCtD
Roflumilast—Connective tissue disorder—Vincristine—sarcoma	0.00642	0.00642	CcSEcCtD
Roflumilast—Malnutrition—Thiotepa—sarcoma	0.00641	0.00641	CcSEcCtD
Roflumilast—Rhinitis—Mitoxantrone—sarcoma	0.00638	0.00638	CcSEcCtD
Roflumilast—Tension—Thiotepa—sarcoma	0.00629	0.00629	CcSEcCtD
Roflumilast—Nervousness—Thiotepa—sarcoma	0.00623	0.00623	CcSEcCtD
Roflumilast—Back pain—Thiotepa—sarcoma	0.0062	0.0062	CcSEcCtD
Roflumilast—Cardiac disorder—Vincristine—sarcoma	0.00606	0.00606	CcSEcCtD
Roflumilast—Pneumonia—Etoposide—sarcoma	0.00593	0.00593	CcSEcCtD
Roflumilast—Ill-defined disorder—Dactinomycin—sarcoma	0.00591	0.00591	CcSEcCtD
Roflumilast—Infestation NOS—Etoposide—sarcoma	0.0059	0.0059	CcSEcCtD
Roflumilast—Infestation—Etoposide—sarcoma	0.0059	0.0059	CcSEcCtD
Roflumilast—Mediastinal disorder—Vincristine—sarcoma	0.00589	0.00589	CcSEcCtD
Roflumilast—Malaise—Dactinomycin—sarcoma	0.00574	0.00574	CcSEcCtD
Roflumilast—Mental disorder—Vincristine—sarcoma	0.00572	0.00572	CcSEcCtD
Roflumilast—Hepatobiliary disease—Etoposide—sarcoma	0.00558	0.00558	CcSEcCtD
Roflumilast—Back pain—Vincristine—sarcoma	0.0055	0.0055	CcSEcCtD
Roflumilast—Myalgia—Thiotepa—sarcoma	0.00546	0.00546	CcSEcCtD
Roflumilast—Anxiety—Thiotepa—sarcoma	0.00544	0.00544	CcSEcCtD
Roflumilast—Dysgeusia—Mitoxantrone—sarcoma	0.00542	0.00542	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00542	0.00542	CcSEcCtD
Roflumilast—Myalgia—Dactinomycin—sarcoma	0.00542	0.00542	CcSEcCtD
Roflumilast—Back pain—Mitoxantrone—sarcoma	0.00536	0.00536	CcSEcCtD
Roflumilast—Discomfort—Dactinomycin—sarcoma	0.00535	0.00535	CcSEcCtD
Roflumilast—Infection—Thiotepa—sarcoma	0.0052	0.0052	CcSEcCtD
Roflumilast—Infection—Dactinomycin—sarcoma	0.00516	0.00516	CcSEcCtD
Roflumilast—Ill-defined disorder—Mitoxantrone—sarcoma	0.00514	0.00514	CcSEcCtD
Roflumilast—Nervous system disorder—Thiotepa—sarcoma	0.00513	0.00513	CcSEcCtD
Roflumilast—Vertigo—Vincristine—sarcoma	0.00511	0.00511	CcSEcCtD
Roflumilast—Skin disorder—Thiotepa—sarcoma	0.00508	0.00508	CcSEcCtD
Roflumilast—Malaise—Mitoxantrone—sarcoma	0.00499	0.00499	CcSEcCtD
Roflumilast—Cardiac disorder—Etoposide—sarcoma	0.00491	0.00491	CcSEcCtD
Roflumilast—Myalgia—Vincristine—sarcoma	0.00484	0.00484	CcSEcCtD
Roflumilast—Immune system disorder—Etoposide—sarcoma	0.00478	0.00478	CcSEcCtD
Roflumilast—Mediastinal disorder—Etoposide—sarcoma	0.00477	0.00477	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00477	0.00477	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00473	0.00473	CcSEcCtD
Roflumilast—Myalgia—Mitoxantrone—sarcoma	0.00472	0.00472	CcSEcCtD
Roflumilast—Anxiety—Mitoxantrone—sarcoma	0.0047	0.0047	CcSEcCtD
Roflumilast—Discomfort—Mitoxantrone—sarcoma	0.00466	0.00466	CcSEcCtD
Roflumilast—Renal failure acute—Epirubicin—sarcoma	0.00464	0.00464	CcSEcCtD
Roflumilast—Infection—Vincristine—sarcoma	0.00461	0.00461	CcSEcCtD
Roflumilast—Dyspepsia—Thiotepa—sarcoma	0.00461	0.00461	CcSEcCtD
Roflumilast—Nervous system disorder—Vincristine—sarcoma	0.00455	0.00455	CcSEcCtD
Roflumilast—Decreased appetite—Thiotepa—sarcoma	0.00455	0.00455	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Thiotepa—sarcoma	0.00452	0.00452	CcSEcCtD
Roflumilast—Decreased appetite—Dactinomycin—sarcoma	0.00452	0.00452	CcSEcCtD
Roflumilast—Fatigue—Thiotepa—sarcoma	0.00451	0.00451	CcSEcCtD
Roflumilast—Dysgeusia—Etoposide—sarcoma	0.00451	0.00451	CcSEcCtD
Roflumilast—Infection—Mitoxantrone—sarcoma	0.00449	0.00449	CcSEcCtD
Roflumilast—Fatigue—Dactinomycin—sarcoma	0.00448	0.00448	CcSEcCtD
Roflumilast—Constipation—Thiotepa—sarcoma	0.00448	0.00448	CcSEcCtD
Roflumilast—Back pain—Etoposide—sarcoma	0.00446	0.00446	CcSEcCtD
Roflumilast—Muscle spasms—Etoposide—sarcoma	0.00443	0.00443	CcSEcCtD
Roflumilast—Skin disorder—Mitoxantrone—sarcoma	0.00439	0.00439	CcSEcCtD
Roflumilast—Feeling abnormal—Thiotepa—sarcoma	0.00431	0.00431	CcSEcCtD
Roflumilast—Renal failure acute—Doxorubicin—sarcoma	0.0043	0.0043	CcSEcCtD
Roflumilast—Feeling abnormal—Dactinomycin—sarcoma	0.00428	0.00428	CcSEcCtD
Roflumilast—Gastrointestinal pain—Thiotepa—sarcoma	0.00428	0.00428	CcSEcCtD
Roflumilast—Ill-defined disorder—Etoposide—sarcoma	0.00427	0.00427	CcSEcCtD
Roflumilast—Gastrointestinal pain—Dactinomycin—sarcoma	0.00425	0.00425	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Vincristine—sarcoma	0.00423	0.00423	CcSEcCtD
Roflumilast—Insomnia—Vincristine—sarcoma	0.0042	0.0042	CcSEcCtD
Roflumilast—Urticaria—Thiotepa—sarcoma	0.00416	0.00416	CcSEcCtD
Roflumilast—Malaise—Etoposide—sarcoma	0.00415	0.00415	CcSEcCtD
Roflumilast—Vertigo—Etoposide—sarcoma	0.00414	0.00414	CcSEcCtD
Roflumilast—Abdominal pain—Thiotepa—sarcoma	0.00414	0.00414	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00412	0.00412	CcSEcCtD
Roflumilast—Abdominal pain—Dactinomycin—sarcoma	0.00411	0.00411	CcSEcCtD
Roflumilast—Decreased appetite—Vincristine—sarcoma	0.00403	0.00403	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Vincristine—sarcoma	0.00401	0.00401	CcSEcCtD
Roflumilast—Fatigue—Vincristine—sarcoma	0.004	0.004	CcSEcCtD
Roflumilast—Dyspepsia—Mitoxantrone—sarcoma	0.00398	0.00398	CcSEcCtD
Roflumilast—Constipation—Vincristine—sarcoma	0.00397	0.00397	CcSEcCtD
Roflumilast—Decreased appetite—Mitoxantrone—sarcoma	0.00393	0.00393	CcSEcCtD
Roflumilast—Fatigue—Mitoxantrone—sarcoma	0.0039	0.0039	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.0039	0.0039	CcSEcCtD
Roflumilast—Discomfort—Etoposide—sarcoma	0.00388	0.00388	CcSEcCtD
Roflumilast—Constipation—Mitoxantrone—sarcoma	0.00387	0.00387	CcSEcCtD
Roflumilast—Hypersensitivity—Thiotepa—sarcoma	0.00386	0.00386	CcSEcCtD
Roflumilast—Hypersensitivity—Dactinomycin—sarcoma	0.00383	0.00383	CcSEcCtD
Roflumilast—Gastrointestinal pain—Vincristine—sarcoma	0.0038	0.0038	CcSEcCtD
Roflumilast—Gastritis—Epirubicin—sarcoma	0.0038	0.0038	CcSEcCtD
Roflumilast—Asthenia—Thiotepa—sarcoma	0.00376	0.00376	CcSEcCtD
Roflumilast—Infection—Etoposide—sarcoma	0.00374	0.00374	CcSEcCtD
Roflumilast—Asthenia—Dactinomycin—sarcoma	0.00373	0.00373	CcSEcCtD
Roflumilast—Feeling abnormal—Mitoxantrone—sarcoma	0.00373	0.00373	CcSEcCtD
Roflumilast—Influenza—Epirubicin—sarcoma	0.00371	0.00371	CcSEcCtD
Roflumilast—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0037	0.0037	CcSEcCtD
Roflumilast—Abdominal pain—Vincristine—sarcoma	0.00367	0.00367	CcSEcCtD
Roflumilast—Skin disorder—Etoposide—sarcoma	0.00365	0.00365	CcSEcCtD
Roflumilast—Urticaria—Mitoxantrone—sarcoma	0.00359	0.00359	CcSEcCtD
Roflumilast—Diarrhoea—Thiotepa—sarcoma	0.00358	0.00358	CcSEcCtD
Roflumilast—Abdominal pain—Mitoxantrone—sarcoma	0.00357	0.00357	CcSEcCtD
Roflumilast—Diarrhoea—Dactinomycin—sarcoma	0.00355	0.00355	CcSEcCtD
Roflumilast—Gastritis—Doxorubicin—sarcoma	0.00351	0.00351	CcSEcCtD
Roflumilast—Dizziness—Thiotepa—sarcoma	0.00346	0.00346	CcSEcCtD
Roflumilast—Influenza—Doxorubicin—sarcoma	0.00343	0.00343	CcSEcCtD
Roflumilast—Hypersensitivity—Vincristine—sarcoma	0.00342	0.00342	CcSEcCtD
Roflumilast—Weight decreased—Epirubicin—sarcoma	0.00335	0.00335	CcSEcCtD
Roflumilast—Hypersensitivity—Mitoxantrone—sarcoma	0.00333	0.00333	CcSEcCtD
Roflumilast—Asthenia—Vincristine—sarcoma	0.00333	0.00333	CcSEcCtD
Roflumilast—Vomiting—Thiotepa—sarcoma	0.00333	0.00333	CcSEcCtD
Roflumilast—Pneumonia—Epirubicin—sarcoma	0.00332	0.00332	CcSEcCtD
Roflumilast—Infestation NOS—Epirubicin—sarcoma	0.0033	0.0033	CcSEcCtD
Roflumilast—Infestation—Epirubicin—sarcoma	0.0033	0.0033	CcSEcCtD
Roflumilast—Vomiting—Dactinomycin—sarcoma	0.0033	0.0033	CcSEcCtD
Roflumilast—Rash—Thiotepa—sarcoma	0.0033	0.0033	CcSEcCtD
Roflumilast—Dermatitis—Thiotepa—sarcoma	0.0033	0.0033	CcSEcCtD
Roflumilast—Headache—Thiotepa—sarcoma	0.00328	0.00328	CcSEcCtD
Roflumilast—Rash—Dactinomycin—sarcoma	0.00328	0.00328	CcSEcCtD
Roflumilast—Decreased appetite—Etoposide—sarcoma	0.00327	0.00327	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Etoposide—sarcoma	0.00325	0.00325	CcSEcCtD
Roflumilast—Asthenia—Mitoxantrone—sarcoma	0.00324	0.00324	CcSEcCtD
Roflumilast—Fatigue—Etoposide—sarcoma	0.00324	0.00324	CcSEcCtD
Roflumilast—Constipation—Etoposide—sarcoma	0.00322	0.00322	CcSEcCtD
Roflumilast—Urinary tract infection—Epirubicin—sarcoma	0.00321	0.00321	CcSEcCtD
Roflumilast—Diarrhoea—Vincristine—sarcoma	0.00318	0.00318	CcSEcCtD
Roflumilast—Hepatobiliary disease—Epirubicin—sarcoma	0.00313	0.00313	CcSEcCtD
Roflumilast—Nausea—Thiotepa—sarcoma	0.00311	0.00311	CcSEcCtD
Roflumilast—Weight decreased—Doxorubicin—sarcoma	0.0031	0.0031	CcSEcCtD
Roflumilast—Sinusitis—Epirubicin—sarcoma	0.0031	0.0031	CcSEcCtD
Roflumilast—Feeling abnormal—Etoposide—sarcoma	0.0031	0.0031	CcSEcCtD
Roflumilast—Diarrhoea—Mitoxantrone—sarcoma	0.00309	0.00309	CcSEcCtD
Roflumilast—Nausea—Dactinomycin—sarcoma	0.00309	0.00309	CcSEcCtD
Roflumilast—Pneumonia—Doxorubicin—sarcoma	0.00308	0.00308	CcSEcCtD
Roflumilast—Gastrointestinal pain—Etoposide—sarcoma	0.00307	0.00307	CcSEcCtD
Roflumilast—Dizziness—Vincristine—sarcoma	0.00307	0.00307	CcSEcCtD
Roflumilast—Infestation—Doxorubicin—sarcoma	0.00306	0.00306	CcSEcCtD
Roflumilast—Infestation NOS—Doxorubicin—sarcoma	0.00306	0.00306	CcSEcCtD
Roflumilast—Urticaria—Etoposide—sarcoma	0.00299	0.00299	CcSEcCtD
Roflumilast—Rhinitis—Epirubicin—sarcoma	0.00297	0.00297	CcSEcCtD
Roflumilast—Abdominal pain—Etoposide—sarcoma	0.00297	0.00297	CcSEcCtD
Roflumilast—Urinary tract infection—Doxorubicin—sarcoma	0.00297	0.00297	CcSEcCtD
Roflumilast—Vomiting—Vincristine—sarcoma	0.00295	0.00295	CcSEcCtD
Roflumilast—Rash—Vincristine—sarcoma	0.00293	0.00293	CcSEcCtD
Roflumilast—Dermatitis—Vincristine—sarcoma	0.00292	0.00292	CcSEcCtD
Roflumilast—Connective tissue disorder—Epirubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Roflumilast—Headache—Vincristine—sarcoma	0.00291	0.00291	CcSEcCtD
Roflumilast—Hepatobiliary disease—Doxorubicin—sarcoma	0.00289	0.00289	CcSEcCtD
Roflumilast—Vomiting—Mitoxantrone—sarcoma	0.00287	0.00287	CcSEcCtD
Roflumilast—Sinusitis—Doxorubicin—sarcoma	0.00287	0.00287	CcSEcCtD
Roflumilast—Rash—Mitoxantrone—sarcoma	0.00285	0.00285	CcSEcCtD
Roflumilast—Dermatitis—Mitoxantrone—sarcoma	0.00285	0.00285	CcSEcCtD
Roflumilast—Headache—Mitoxantrone—sarcoma	0.00283	0.00283	CcSEcCtD
Roflumilast—Hypersensitivity—Etoposide—sarcoma	0.00277	0.00277	CcSEcCtD
Roflumilast—Nausea—Vincristine—sarcoma	0.00276	0.00276	CcSEcCtD
Roflumilast—Cardiac disorder—Epirubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Roflumilast—Rhinitis—Doxorubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Roflumilast—Asthenia—Etoposide—sarcoma	0.0027	0.0027	CcSEcCtD
Roflumilast—Connective tissue disorder—Doxorubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Roflumilast—Nausea—Mitoxantrone—sarcoma	0.00269	0.00269	CcSEcCtD
Roflumilast—Immune system disorder—Epirubicin—sarcoma	0.00268	0.00268	CcSEcCtD
Roflumilast—Mediastinal disorder—Epirubicin—sarcoma	0.00267	0.00267	CcSEcCtD
Roflumilast—Mental disorder—Epirubicin—sarcoma	0.0026	0.0026	CcSEcCtD
Roflumilast—Malnutrition—Epirubicin—sarcoma	0.00258	0.00258	CcSEcCtD
Roflumilast—Diarrhoea—Etoposide—sarcoma	0.00257	0.00257	CcSEcCtD
Roflumilast—Cardiac disorder—Doxorubicin—sarcoma	0.00255	0.00255	CcSEcCtD
Roflumilast—Tension—Epirubicin—sarcoma	0.00253	0.00253	CcSEcCtD
Roflumilast—Dysgeusia—Epirubicin—sarcoma	0.00253	0.00253	CcSEcCtD
Roflumilast—Nervousness—Epirubicin—sarcoma	0.00251	0.00251	CcSEcCtD
Roflumilast—Back pain—Epirubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Roflumilast—Dizziness—Etoposide—sarcoma	0.00249	0.00249	CcSEcCtD
Roflumilast—Muscle spasms—Epirubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Roflumilast—Immune system disorder—Doxorubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Roflumilast—Mediastinal disorder—Doxorubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Roflumilast—Mental disorder—Doxorubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Roflumilast—Ill-defined disorder—Epirubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Roflumilast—Vomiting—Etoposide—sarcoma	0.00239	0.00239	CcSEcCtD
Roflumilast—Malnutrition—Doxorubicin—sarcoma	0.00239	0.00239	CcSEcCtD
Roflumilast—Rash—Etoposide—sarcoma	0.00237	0.00237	CcSEcCtD
Roflumilast—Dermatitis—Etoposide—sarcoma	0.00237	0.00237	CcSEcCtD
Roflumilast—Headache—Etoposide—sarcoma	0.00236	0.00236	CcSEcCtD
Roflumilast—Tension—Doxorubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Roflumilast—Dysgeusia—Doxorubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Roflumilast—Malaise—Epirubicin—sarcoma	0.00233	0.00233	CcSEcCtD
Roflumilast—Nervousness—Doxorubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Roflumilast—Vertigo—Epirubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Roflumilast—Back pain—Doxorubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Roflumilast—Muscle spasms—Doxorubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Roflumilast—Palpitations—Epirubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Roflumilast—Nausea—Etoposide—sarcoma	0.00223	0.00223	CcSEcCtD
Roflumilast—Ill-defined disorder—Doxorubicin—sarcoma	0.00222	0.00222	CcSEcCtD
Roflumilast—Myalgia—Epirubicin—sarcoma	0.0022	0.0022	CcSEcCtD
Roflumilast—Anxiety—Epirubicin—sarcoma	0.00219	0.00219	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00218	0.00218	CcSEcCtD
Roflumilast—Discomfort—Epirubicin—sarcoma	0.00217	0.00217	CcSEcCtD
Roflumilast—Malaise—Doxorubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Roflumilast—Vertigo—Doxorubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Roflumilast—Palpitations—Doxorubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Roflumilast—Infection—Epirubicin—sarcoma	0.00209	0.00209	CcSEcCtD
Roflumilast—Nervous system disorder—Epirubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Roflumilast—Skin disorder—Epirubicin—sarcoma	0.00205	0.00205	CcSEcCtD
Roflumilast—Myalgia—Doxorubicin—sarcoma	0.00203	0.00203	CcSEcCtD
Roflumilast—Anxiety—Doxorubicin—sarcoma	0.00203	0.00203	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Roflumilast—Discomfort—Doxorubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Roflumilast—Infection—Doxorubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Roflumilast—Nervous system disorder—Doxorubicin—sarcoma	0.00191	0.00191	CcSEcCtD
Roflumilast—Insomnia—Epirubicin—sarcoma	0.00191	0.00191	CcSEcCtD
Roflumilast—Skin disorder—Doxorubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Roflumilast—Dyspepsia—Epirubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Roflumilast—Decreased appetite—Epirubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Epirubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Roflumilast—Fatigue—Epirubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Roflumilast—Constipation—Epirubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Roflumilast—Insomnia—Doxorubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Roflumilast—Feeling abnormal—Epirubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Roflumilast—Gastrointestinal pain—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Roflumilast—Dyspepsia—Doxorubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Roflumilast—Decreased appetite—Doxorubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Roflumilast—Fatigue—Doxorubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Roflumilast—Urticaria—Epirubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Roflumilast—Constipation—Doxorubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Roflumilast—Abdominal pain—Epirubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Roflumilast—Feeling abnormal—Doxorubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Roflumilast—Gastrointestinal pain—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Roflumilast—Hypersensitivity—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Roflumilast—Urticaria—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Roflumilast—Abdominal pain—Doxorubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Roflumilast—Asthenia—Epirubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Roflumilast—Diarrhoea—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Roflumilast—Hypersensitivity—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Roflumilast—Asthenia—Doxorubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Roflumilast—Dizziness—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Roflumilast—Vomiting—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Roflumilast—Diarrhoea—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Roflumilast—Rash—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Roflumilast—Dermatitis—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Roflumilast—Headache—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Roflumilast—Dizziness—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Roflumilast—Nausea—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Roflumilast—Vomiting—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Roflumilast—Rash—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Roflumilast—Dermatitis—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Roflumilast—Headache—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Roflumilast—Nausea—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
